An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A big research review looked at what happens when people stop taking popular weight-loss drugs like Ozempic or Wegovy. The headline finding: on average, people regained nearly 2 pounds a month after stopping these medications. That doesn’t mean everyone gains the same amount, but across the studies the trend was clear — stopping the drugs usually leads to weight coming back. The medicines involved are semaglutide and similar drugs. Semaglutide is the active ingredient in Ozempic and Wegovy. It’s a man-made version of a natural gut signal that tells your brain you’re full and slows how quickly your stomach empties. People take it by injection and it helps reduce appetite and food intake, which leads to weight loss for many users. The paper was a review, meaning researchers gathered results from several studies and pooled them to see the overall pattern. That makes the finding stronger than a single small study, but it also depends on the size and quality of the included studies. The headline number — about 2 pounds a month — is an average. Some people regained less, others regained more. The review focused on what happened after stopping the drugs; it did not mean the drugs failed while people were taking them. In many trials, weight loss occurred while people used the medication, and regain tended to start once treatment stopped. Why this matters is practical. If someone loses weight with these drugs and then stops, they should be prepared for some weight to return unless they keep up other measures like diet and activity. For people considering starting semaglutide for long-term weight control, this raises the question of whether the medication needs to be continued indefinitely to maintain results. Clinicians, insurers, and patients will care because it affects treatment plans, costs, and expectations. There are important caveats. The review summarizes averages and study designs varied — length of treatment, how long people were followed after stopping, and other support they got (like counseling or diet programs) differed. Side effects of these drugs while taking them can include nausea, stomach issues, and rare but serious risks that doctors watch for. The review focuses on what happens after stopping, not on safety in general. Regulatory status: these medicines are approved for certain uses, but any decision to start or stop should be made with a healthcare provider. People with certain conditions or pregnant people should not use them without medical advice. Bottom line: semaglutide drugs can help with weight loss, but stopping them often leads to a steady return of weight — roughly two pounds a month on average — so long-term plans and medical guidance matter.
Source: Medical Daily